Amplia Therapeutics: Melbourne‑Based Biotech Driving Immuno‑Oncology Innovation
Amplia Therapeutics, a Melbourne‑based biotech, champions immuno‑oncology, targeting cancer breakthroughs amid volatile stock swings and growth‑oriented R&D.
2 minutes to read

